(Q38102924)

28 August 2017

title

Circulating microRNAs as novel biomarkers for diabetes mellitus (English)

1 reference

28 August 2017

0 references

1 reference

Romano Regazzi

2

0 references

Claudiane Guay

series ordinal

1

object named as

Claudiane Guay

1 reference

28 August 2017

publication date

30 April 2013

1 reference

Nature Reviews Endocrinology

28 August 2017

published in

1 reference

28 August 2017

volume

9

1 reference

28 August 2017

issue

9

1 reference

28 August 2017

page(s)

513-521

1 reference

IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Mediators and mechanisms of pancreatic beta-cell death in type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Diagnosis and classification of diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Islet beta cell failure in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Type 2 diabetes: principles of pathogenesis and therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Type 1 diabetes islet autoantibody markers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Use of multiple metabolic and genetic markers to improve the prediction of type 2 diabetes: the EPIC-Potsdam Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Microvesicles/exosomes as potential novel biomarkers of metabolic diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

MicroRNAs: genomics, biogenesis, mechanism, and function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Biological principles of microRNA-mediated regulation: shared themes amid diversity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

A pancreatic islet-specific microRNA regulates insulin secretion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

miR-375 maintains normal pancreatic alpha- and beta-cell mass

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

MicroRNAs: a new ray of hope for diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Role of microRNAs in diabetes and its cardiovascular complications.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Diabetes mellitus, a microRNA-related disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Changes in microRNA expression contribute to pancreatic β-cell dysfunction in prediabetic NOD mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Obesity and genetics regulate microRNAs in islets, liver, and adipose of diabetic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

MicroRNAs 103 and 107 regulate insulin sensitivity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

The microRNA signature in response to insulin reveals its implication in the transcriptional action of insulin in human skeletal muscle and the role of a sterol regulatory element-binding protein-1c/myocyte enhancer factor 2C pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Diabetes complications: the microRNA perspective.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

MicroRNAs and diabetic complications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Circulating microRNAs as stable blood-based markers for cancer detection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

MicroRNA isolation and stability in stored RNA samples

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

The MicroRNA Spectrum in 12 Body Fluids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Serum microRNAs are promising novel biomarkers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Toward the blood-borne miRNome of human diseases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

MicroRNAs as biomarkers in rheumatic diseases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Serum miR-146a and miR-223 as potential new biomarkers for sepsis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Circulating miRNA profiles in patients with metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Circulating miR-375 as a biomarker of β-cell death and diabetes in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

MicroRNAs miR-21a and miR-93 are down regulated in peripheral blood mononuclear cells (PBMCs) from patients with type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Increased expression of microRNA miR-326 in type 1 diabetic patients with ongoing islet autoimmunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

31 March 2020

Epidemiology of diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Circulating microRNAs in patients with coronary artery disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

miR-126 regulates angiogenic signaling and vascular integrity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Circulating miRNAs: reflecting or affecting cardiovascular disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Towards understanding the inherited susceptibility for nephropathy in diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Diabetic kidney disease with and without albuminuria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Regression of microalbuminuria in type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Circulating microRNAs are not eliminated by hemodialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Circulating microRNA expression is reduced in chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Elevated levels of miR-146a and miR-155 in kidney biopsy and urine from patients with IgA nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Urinary microRNA-10a and microRNA-30d serve as novel, sensitive and specific biomarkers for kidney injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

The role of non-coding RNAs in diabetic nephropathy: potential applications as biomarkers for disease development and progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Exosomes and the kidney: prospects for diagnosis and therapy of renal diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Analysis of urinary microRNAs in chronic kidney disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Urinary microRNA profiling in the nephropathy of type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Early second-trimester serum miRNA profiling predicts gestational diabetes mellitus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Detection and Characterization of Placental MicroRNAs in Maternal Plasma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Analysis of circulating microRNA: preanalytical and analytical challenges.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Changes in circulating microRNA levels associated with prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Characterization of vesicles secreted from insulinoma NIT-1 cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Characterization of membrane-shed microvesicles from cytokine-stimulated β-cells using proteomics strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Insulinoma-released exosomes or microparticles are immunostimulatory and can activate autoreactive T cells spontaneously developed in nonobese diabetic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Identification of mammalian microRNA host genes and transcription units

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

MicroRNA genes are transcribed by RNA polymerase II

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Intronic microRNA precursors that bypass Drosha processing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Specificity of microRNA target selection in translational repression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Exfoliation of membrane ecto-enzymes in the form of micro-vesicles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Secretory mechanisms and intercellular transfer of microRNAs in living cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Secreted monocytic miR-150 enhances targeted endothelial cell migration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.86

Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes)

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23629540

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Biomarkers for type 1 diabetes.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23629540

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23629540

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRENDO.2013.86

1 reference

28 August 2017

1 reference